---
category: listing
circular_id: c46f96d78fa78b23
date: '2025-08-14'
description: 20,75,073 new equity shares of Vivo Bio tech Ltd listed on BSE with effect
  from August 18, 2025, issued on preferential basis pursuant to warrant conversion.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={A868A611-5A76-45AA-9575-7FE5F78746FB}&noticeno=20250814-14&dt=08/14/2025&icount=14&totcount=59&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of new shares through warrant conversion with standard
  lock-in period
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250814-14&attachedId=
processing:
  attempts: 1
  content_hash: c1fadaa8db54e5b7
  processed_at: '2025-08-14T15:36:39.432962'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-14T09:50:00+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={A868A611-5A76-45AA-9575-7FE5F78746FB}&noticeno=20250814-14&dt=08/14/2025&icount=14&totcount=59&flag=0
severity: low
source: bse
stocks:
- VIVOBIO
tags:
- listing
- equity-shares
- preferential-issue
- warrant-conversion
- lock-in
title: Listing of New Securities of Vivo Bio tech Ltd
---

## Summary

BSE has announced the listing of 20,75,073 new equity shares of Vivo Bio tech Ltd (Scrip Code: 511509) with effect from Monday, August 18, 2025. These shares were issued at Rs. 45/- per share (Rs. 10/- face value + Rs. 35/- premium) to non-promoters on preferential basis pursuant to conversion of warrants.

## Key Points

- Total shares listed: 20,75,073 equity shares of Rs. 10/- each
- Issue price: Rs. 45/- per share (including Rs. 35/- premium)
- Trading commencement: August 18, 2025
- Distribution numbers: 17924817 to 19999889
- ISIN: INE380K01017
- Shares rank pari-passu with existing equity shares

## Regulatory Changes

No regulatory changes introduced. This is a routine listing following warrant conversion.

## Compliance Requirements

All shares are subject to lock-in restrictions until February 28, 2026, across four tranches with different allotment dates.

## Important Dates

- Trading commencement: August 18, 2025
- Allotment dates: May 28, 2025; June 18, 2025; June 25, 2025; July 3, 2025
- Lock-in expiry: February 28, 2026 (for all tranches)

## Impact Assessment

Minimal market impact expected as this represents routine listing of shares from warrant conversion. The lock-in period until February 2026 ensures these shares cannot be traded immediately, limiting any potential dilution impact on existing shareholders.